About
Open menu
Overview
Our Team
Scientific Advisory Board
Contact
Science
Open menu
PAM Pathway
Publications
Pipeline
Open menu
Overview
Gedatolisib
Expanded Access
Clinical Trials
Open menu
VIKTORIA-1: Breast Cancer
VIKTORIA-2: Breast Cancer
CELC-G-201: Prostate Cancer
Investors
Open menu
Overview
Press Release
Events & Presentations
Corporate Governance
SEC Filings
Stock Quote
Analyst Coverage
IR Alerts
Careers
Open menu
Overview
Culture & Benefits
Open Positions
X
NEWS
CONTACT
X
Our approach
Open menu
Our Approach
Publications
Our Pipeline
Open menu
Our Pipeline
PI3K/AKT/mTOR (PAM) Pathway
Gedatolisib
Expanded Access Program
CLINICAL TRIALS
Open menu
VIKTORIA-1: Breast Cancer
VIKTORIA-2: Breast Cancer
CELC-G-201: Prostate Cancer
About
Open menu
About
Our Team
Board of Directors
Scientific Advisory Board
Investors – staging
Open menu
Investors – staging
Press Releases – staging
Events & Presentations – Staging
Corporate Governance
SEC Filings Staging
Stock Quote Staging
Stock Chart Staging
Analyst Coverage – staging
IR Alerts – Staging
CAREERS
Open menu
Overview
Culture & Benefits
Hiring, development & advancement
Open Positions
X
Unraveling complexity. Harnessing insights.
NEWS
CONTACT
X
Our approach
Open menu
Our Approach
Publications
Our Pipeline
Open menu
Our Pipeline
PI3K/AKT/mTOR (PAM) Pathway
Gedatolisib
Expanded Access Program
CLINICAL TRIALS
Open menu
VIKTORIA-1: Breast Cancer
VIKTORIA-2: Breast Cancer
CELC-G-201: Prostate Cancer
About
Open menu
About
Our Team
Board of Directors
Scientific Advisory Board
Investors – staging
Open menu
Investors – staging
Press Releases – staging
Events & Presentations – Staging
Corporate Governance
SEC Filings Staging
Stock Quote Staging
Stock Chart Staging
Analyst Coverage – staging
IR Alerts – Staging
CAREERS
Open menu
Overview
Culture & Benefits
Hiring, development & advancement
Open Positions
X
About
Open menu
Overview
Our Team
Scientific Advisory Board
Contact
Science
Open menu
PAM Pathway
Publications
Pipeline
Open menu
Overview
Gedatolisib
Expanded Access
Clinical Trials
Open menu
VIKTORIA-1: Breast Cancer
VIKTORIA-2: Breast Cancer
CELC-G-201: Prostate Cancer
Investors
Open menu
Overview
Press Release
Events & Presentations
Corporate Governance
SEC Filings
Stock Quote
Analyst Coverage
IR Alerts
Careers
Open menu
Overview
Culture & Benefits
Open Positions
X
Corporate Menu
Open menu
Our Approach
Our Approach
Nonclinical Research
Publications
Our Pipeline
Our Pipeline
The PI3K – mTOR Pathway
Gedatolisib
Expanded Access Program
About
About
Board of Directors
Scientific Advisory Board
Our Team
News
Contact
IR Menu
Open menu
Investors – staging
Press Releases – staging
Events & Presentations – Staging
Corporate Governance
Committees & Documents – staging
SEC Filings Staging
Stock Quote Staging
Stock Chart Staging
Analyst Coverage – staging
IR Alerts – Staging
Privacy Policy
X
Analyst Coverage
Investor Home
Press Releases – staging
Events & Presentations – Staging
Corporate Governance
Open menu
Committees & Documents – staging
SEC Filings Staging
Stock Quote Staging
Stock Chart Staging
Analyst Coverage – staging
IR Alerts – Staging
Privacy Policy
Firm
Analyst
Cowen and Company, LLC
Tara Bancroft, Ph.D.
Craig-Hallum Capital Group LLC
Chase Knickerbocker
Guggenheim
Brad Canino
H.C. Wainwright & Co.
Swayampakula Ramakanth, Ph.D.
Jefferies LLC
Maury Raycroft, Ph.D.
Leerink Partners LLC
Andrew Berens, M.D.
LifeSci Capital
Oliver McCammon
Needham and Company, LLC
Gil Blum, Ph.D.
Stifel
Stephen D. Willey
Bradley Canino